These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6602460)

  • 21. A microtitre chromogenic substrate assay for factor XII.
    Walshe KJ; Mackie IJ; Gallimore M; Machin SJ
    Thromb Res; 1987 Aug; 47(3):365-71. PubMed ID: 3629562
    [No Abstract]   [Full Text] [Related]  

  • 22. Stable plasma protein solution. Modern preparation methods reduce risk of untoward reactions.
    Schiff P
    Med J Aust; 1982 Jun; 1(12):493. PubMed ID: 6980365
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluid phase activation of Hageman factor (factor XII) in citrated human plasma by bromelain: an application to the indirect enzymatic assay for Hageman factor.
    Oh-ishi S
    Thromb Res; 1982 Sep; 27(5):619-23. PubMed ID: 6983741
    [No Abstract]   [Full Text] [Related]  

  • 24. Prekallikrein activator in human albumin.
    Paton CJ; Kerry PJ
    Lancet; 1981 Oct; 2(8249):747. PubMed ID: 6116876
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contact coagulation factors].
    Kojima T; Saito H
    Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract]   [Full Text] [Related]  

  • 26. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Formation of kallikreins in blood plasma].
    Buluk K; Czokalo M; Malofiejew M; Januszko T
    Acta Physiol Pol; 1968; 19(2):149-61. PubMed ID: 4231294
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of factor XII in plasma using the kallikrein substrate chromozym PK.
    Klessen C; Stürzebecher J; Markwardt F
    Thromb Res; 1982 Mar; 25(6):501-5. PubMed ID: 6921902
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of pentosan polysulphate (SP54) on the human fibrinolytic system.
    Gaffney PJ; Marsh NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):262-71. PubMed ID: 2427409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pre-albumin activator of prekallikrein.
    Kaplan AP; Austen KF
    J Immunol; 1970 Oct; 105(4):802-11. PubMed ID: 5470521
    [No Abstract]   [Full Text] [Related]  

  • 31. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 33. The kinin system of human plasma. IV. The interrelationship between the contact phase of blood coagulation and the plasma kinin system in man.
    Ozge-Anwar AH; Movat HZ; Scott JG
    Thromb Diath Haemorrh; 1972 Feb; 27(1):141-58. PubMed ID: 5033664
    [No Abstract]   [Full Text] [Related]  

  • 34. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma.
    Venneröd AM; Laake K
    Thromb Res; 1976 Apr; 8(4):519-22. PubMed ID: 1273811
    [No Abstract]   [Full Text] [Related]  

  • 35. [Identity of human granulocyte kininogenase and plasminogen activator].
    Ogloblina OG; Platonova LV; Martynov VF; Leont'eva LI; Sorochinskaia EI
    Ukr Biokhim Zh (1978); 1983; 55(3):285-94. PubMed ID: 6346622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardization of prekallikrein activator (PKA): the 1st British reference preparation for PKA.
    Kerry PJ; Curtis AD; Paton CJ; Thomas DP
    Br J Haematol; 1982 Oct; 52(2):275-81. PubMed ID: 6982063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H
    Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843
    [No Abstract]   [Full Text] [Related]  

  • 39. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.